Oscar Health (OSCR) EBIAT (2020 - 2025)
Oscar Health's EBIAT history spans 6 years, with the latest figure at -$352.7 million for Q4 2025.
- For Q4 2025, EBIAT fell 130.08% year-over-year to -$352.7 million; the TTM value through Dec 2025 reached -$443.1 million, down 1810.02%, while the annual FY2025 figure was -$443.2 million, 1796.53% down from the prior year.
- EBIAT reached -$352.7 million in Q4 2025 per OSCR's latest filing, down from -$137.4 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $275.5 million in Q1 2025 to a low of -$352.7 million in Q4 2025.
- Average EBIAT over 5 years is -$93.5 million, with a median of -$100.5 million recorded in 2021.
- Peak YoY movement for EBIAT: skyrocketed 547.87% in 2024, then tumbled 505.76% in 2025.
- A 5-year view of EBIAT shows it stood at -$198.9 million in 2021, then fell by 13.89% to -$226.6 million in 2022, then soared by 33.86% to -$149.8 million in 2023, then decreased by 2.3% to -$153.3 million in 2024, then crashed by 130.08% to -$352.7 million in 2025.
- Per Business Quant, the three most recent readings for OSCR's EBIAT are -$352.7 million (Q4 2025), -$137.4 million (Q3 2025), and -$228.5 million (Q2 2025).